Chapter 17: Problem 4
Provide a definition of chromatin remodeling, and give two exam- ples of this phenomenon.
Short Answer
Step by step solution
Key Concepts
These are the key concepts you need to understand to accurately answer the question.
/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none}
Learning Materials
Features
Discover
Chapter 17: Problem 4
Provide a definition of chromatin remodeling, and give two exam- ples of this phenomenon.
These are the key concepts you need to understand to accurately answer the question.
All the tools & learning materials you need for study success - in one app.
Get started for free
Transcription factors play key roles in the regulation of gene expression, but to do so, they must act within the nucleus. Like most proteins, however, transcription factors are translated in the cytoplasm. To enter the nucleus, transcription factors contain nuclear localization signals, which in some cases can work only when bound to some other molecule such as a steroid hormone. After entering the nucleus, transcription factors must bind to appropriate DNA sites and must interact with other transcription proteins at promoters, enhancers, and silencers. Transcription factors then activate or repress transcription through their activation or repression domains. Many drug therapies target transcription factors. Based on the information provided above, suggest three specific mechanisms through which a successful drug therapy, targeted to a transcription factor, might work.
Describe the organization of the interphase nucleus. Include in your presentation a description of chromosome territories, interchromatin compartments, and transcription factories.
In this chapter, we focused on how eukaryotic genes are regulated at the transcriptional level. Along the way, we found many opportunities to consider the methods and reasoning by which much of this information was acquired. From the explanations given in the chapter, (a) How do we know that promoter and enhancer sequences control the initiation of transcription in eukaryotes? (b) How do we know that the orientation of promoters relative to the transcription start site is important while enhancers are orientation independent? (c) How do we know that eukaryotic transcription factors bind to DNA sequences at or near promoter regions? (d) How do we know that there is an association between disease susceptibility in humans and regulatory DNA sequences?
A particular type of anemia in humans, called \(\beta\) -thalassemia, results from a severe reduction or absence of the normal \(\beta\) -globin chain of hemoglobin. However, the \(\gamma\) -globin chain, normally only expressed during fetal development, can functionally substitute for \(\beta\) -globin. A variety of studies have explored the use of the nucleoside 5 -azacytidine for the expression of \(\gamma\) -globin in adult patients with \(\beta\) -thalassemia. (a) How might 5 -azacytidine lead to expression of \(\gamma\) -globin in adult patients? (b) Explain why this drug may also have some adverse side effects.
Explain how the following mutations would affect transcription of the yeast \(G A L 1\) gene in the presence of galactose. (a) A deletion within the GAL4 gene that removes the region encoding amino acids 1 to 100 . (b) A deletion of the entire \(G A I 3\) gene. (c) A mutation within the \(G A L 80\) gene that blocks the ability of Gal80 protein to interact with Gal3p. (d) A deletion of one of the four UAS elements upstream from the GAL1 gene. (e) A point mutation in the GAL1 core promoter that alters the sequence of the TATA box.
What do you think about this solution?
We value your feedback to improve our textbook solutions.